GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » LSL Pharma Group Inc (TSXV:LSL) » Definitions » Revenue

LSL Pharma Group (TSXV:LSL) Revenue : C$10.03 Mil (TTM As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is LSL Pharma Group Revenue?

LSL Pharma Group's revenue for the three months ended in Dec. 2023 was C$3.46 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was C$10.03 Mil. LSL Pharma Group's Revenue per Share for the three months ended in Dec. 2023 was C$0.04. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$0.13.

During the past 12 months, the average Revenue per Share Growth Rate of LSL Pharma Group was 25.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was 50.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 4 years, LSL Pharma Group's highest 3-Year average Revenue per Share Growth Rate was 50.10% per year. The lowest was 50.10% per year. And the median was 50.10% per year.


LSL Pharma Group Revenue Historical Data

The historical data trend for LSL Pharma Group's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LSL Pharma Group Revenue Chart

LSL Pharma Group Annual Data
Trend Sep20 Dec21 Dec22 Dec23
Revenue
4.82 8.77 8.21 10.03

LSL Pharma Group Quarterly Data
Sep20 Dec20 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.29 2.02 2.03 2.51 3.46

Competitive Comparison of LSL Pharma Group's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, LSL Pharma Group's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


LSL Pharma Group's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, LSL Pharma Group's Revenue distribution charts can be found below:

* The bar in red indicates where LSL Pharma Group's Revenue falls into.



LSL Pharma Group Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$10.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


LSL Pharma Group  (TSXV:LSL) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


LSL Pharma Group Revenue Related Terms

Thank you for viewing the detailed overview of LSL Pharma Group's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


LSL Pharma Group (TSXV:LSL) Business Description

Traded in Other Exchanges
N/A
Address
3030, Le Carrefour Boulevard, Suite 1002, Laval, QC, CAN, H7T 2P5
Website
LSL Pharma Group Inc integrated pharmaceutical company specializing in the development, manufacture and distribution of high-quality natural health products and dietary supplements in solid dosage forms as well as high quality sterile ophthalmic pharmaceutical products.

LSL Pharma Group (TSXV:LSL) Headlines

No Headlines